Is Invesco S&P 500 Equal Weight Materials ETF (RSPM) a Strong ETF Right Now?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2024
0mins
Should l Buy FMC?
Source: NASDAQ.COM
Invesco S&P 500 Equal Weight Materials ETF Overview: Launched in 2006, the Invesco S&P 500 Equal Weight Materials ETF (RSPM) offers broad exposure to the materials sector with a low expense ratio of 0.40% and a year-to-date return of approximately 11.11%.
Investment Considerations: While RSPM aims to outperform the materials ETFs segment, investors may also consider other options like the Materials Select Sector SPDR ETF (XLB) and FlexShares Morningstar Global Upstream Natural Resources ETF (GUNR), which have lower expense ratios and larger asset bases.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FMC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FMC
Wall Street analysts forecast FMC stock price to rise
14 Analyst Rating
3 Buy
10 Hold
1 Sell
Hold
Current: 14.830
Low
13.00
Averages
19.08
High
28.00
Current: 14.830
Low
13.00
Averages
19.08
High
28.00
About FMC
FMC Corporation is a global agricultural sciences company engaged in providing farmers solutions that increase the productivity and resilience of their land. The Company’s crop protection solutions, including biologicals, crop nutrition, digital and precision agriculture, enable growers and crop advisers to address their challenges economically while protecting the environment. Its portfolio consists of three major pesticide categories: insecticides, herbicides and fungicides. The majority of its product lines consist of insecticides and herbicides, and it has a portfolio of fungicides mainly used in high-value crop segments. Its insecticides are used to control a wide spectrum of pests, while its herbicide portfolio primarily targets a large variety of difficult-to-control weeds. In addition, it is also investing in its Plant Health program, which includes biologicals, crop nutrition, and seed treatment products. Biological technologies serve as complements to its synthetic products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
FMC Stock Outlook: Challenges Ahead
- Declining Performance: FMC's revenue fell 5% last year to $3.5 billion, indicating challenges in its core product portfolio, with management expecting another 5% revenue decline this year, putting pressure on the stock price.
- Significant Losses: Under GAAP, FMC reported a loss from continuing operations of $2.2 billion compared to a profit of $403.4 million last year, reflecting financial distress and the impact of restructuring costs.
- Acquisition Potential: Although FMC announced it would explore strategic options, including a potential acquisition, its stock has dropped 68.5% over the past year, currently priced at $13.09, requiring a 15% premium to reach the $15 target.
- Valuation Challenges: FMC's price-to-sales ratio stands at 0.5, down from 1.2 a year ago, suggesting potential value, but management's guidance of declining sales makes the likelihood of the stock reaching $15 seem slim.
See More
Investigation into FMC Corporation for Securities Fraud
- Investigation Launched: Pomerantz LLP is investigating whether FMC Corporation and its executives have engaged in securities fraud or other unlawful business practices, aiming to protect investor rights and potentially initiate a class action lawsuit.
- Financial Warning: In a press release dated February 4, 2026, FMC projected full-year revenue between $3.60 billion and $3.80 billion, reflecting a 5% decline at the midpoint compared to the previous year, while adjusted EBITDA is expected to be between $670 million and $730 million, a 17% drop primarily due to lower prices.
- Stock Price Reaction: Following the financial warning, FMC's stock price fell by $3.32, or 19.54%, closing at $13.67 per share on February 5, 2026, indicating market concerns regarding the company's outlook.
- Legal Context: Pomerantz LLP, a prominent firm in securities class action litigation with over 85 years of experience, focuses on advocating for victims of securities fraud and corporate misconduct, which could significantly impact FMC's legal liabilities.
See More
FMC Corporation Announces Q1 2026 Earnings Release Date
- Earnings Release Schedule: FMC Corporation has announced that it will release its Q1 2026 earnings on April 29, 2026, after market close, ensuring timely access to financial information for investors via PR Newswire and the company's website.
- Webcast Timing: The company will host a public webcast conference call on April 30, 2026, at 9:00 a.m. ET, aimed at enhancing transparency and facilitating direct communication with investors.
- Dial-In Information: The conference call offers multiple dial-in options, including local and toll-free numbers for the U.S., ensuring global investor participation and enhancing interaction between the company and its stakeholders.
- Company Overview: FMC is a global agricultural sciences company dedicated to helping growers adapt to environmental changes by providing innovative crop protection solutions, showcasing its commitment and strategic direction in sustainable agriculture.
See More
FMC Corp's Strategic Review Sparks Market Interest
- Significant Stock Volatility: FMC's stock has plummeted approximately 90% from its 2022 highs, facing heavy debt and patent expirations, yet the market shows disagreement on its future value, with a median analyst price target of $14.00 and a high of $43.00, indicating varied investor perspectives.
- New Product Development Progress: FMC is actively advancing 19 new active ingredients for weed controllers and insecticides, with four products currently in commercial rollout, projected to achieve approximately $200 million in sales by 2025, despite falling short of the $250 million target, reflecting strong market demand with a 54% year-over-year growth.
- Debt Management Commitment: FMC plans to pay down $1 billion in debt through asset sales and licensing agreements by 2026, including the previously announced sale of its Indian commercial business, while continuing its active ingredients manufacturing operations in India, aiming to improve financial health and bolster investor confidence.
- Enhanced Market Competitiveness: Rimisoxafen's
See More
FMC Shares Plummet, Investors Face Challenges
- Significant Stock Decline: FMC's shares have plummeted by approximately two-thirds over the past year, currently priced at $13.11 with a market cap of $1.6 billion, reflecting severe challenges and financial distress in the agricultural chemicals sector.
- Poor Financial Performance: FMC's revenue for 2024 is reported at $4.2 billion, with an expected 8% decline to $3.9 billion in 2025, alongside a 7% drop in adjusted EBITDA and a 15% decrease in adjusted EPS, indicating a decline in profitability under pressure from weak demand and patent expirations.
- Strategic Adjustments and Dividend Cut: The management's decision to cut dividends by 86% and consider
See More
FMC Shares Plummet, Yet Potential Investment Opportunities Arise
- Significant Stock Decline: FMC's shares have plummeted by approximately two-thirds over the past year due to both industry-specific and company-specific challenges, resulting in poor financial performance and diminished investor confidence.
- Strategic Decisions and Dividend Cut: The management has opted for an 86% dividend cut and is considering 'strategic alternatives,' including a potential sale of the company, which has led to negative investor reactions and further exacerbated the stock's decline.
- Future Revenue Guidance: According to management's 2026 guidance, revenue is expected to fall by 5.2% to $3.6 billion, with adjusted EBITDA projected between $670 million and $730 million, indicating ongoing financial pressures for the company.
- Potential Catalysts: Despite facing numerous challenges, FMC has two potential catalysts that could play out over the next year, including the launch of a new wave of patented crop protection products, although the market impact of these products may take years to materialize.
See More
FMC Stock Outlook: Challenges Ahead
- Declining Performance: FMC's revenue fell 5% last year to $3.5 billion, indicating challenges in its core product portfolio, with management expecting another 5% revenue decline this year, putting pressure on the stock price.
- Significant Losses: Under GAAP, FMC reported a loss from continuing operations of $2.2 billion compared to a profit of $403.4 million last year, reflecting financial distress and the impact of restructuring costs.
- Acquisition Potential: Although FMC announced it would explore strategic options, including a potential acquisition, its stock has dropped 68.5% over the past year, currently priced at $13.09, requiring a 15% premium to reach the $15 target.
- Valuation Challenges: FMC's price-to-sales ratio stands at 0.5, down from 1.2 a year ago, suggesting potential value, but management's guidance of declining sales makes the likelihood of the stock reaching $15 seem slim.
See More
Investigation into FMC Corporation for Securities Fraud
- Investigation Launched: Pomerantz LLP is investigating whether FMC Corporation and its executives have engaged in securities fraud or other unlawful business practices, aiming to protect investor rights and potentially initiate a class action lawsuit.
- Financial Warning: In a press release dated February 4, 2026, FMC projected full-year revenue between $3.60 billion and $3.80 billion, reflecting a 5% decline at the midpoint compared to the previous year, while adjusted EBITDA is expected to be between $670 million and $730 million, a 17% drop primarily due to lower prices.
- Stock Price Reaction: Following the financial warning, FMC's stock price fell by $3.32, or 19.54%, closing at $13.67 per share on February 5, 2026, indicating market concerns regarding the company's outlook.
- Legal Context: Pomerantz LLP, a prominent firm in securities class action litigation with over 85 years of experience, focuses on advocating for victims of securities fraud and corporate misconduct, which could significantly impact FMC's legal liabilities.
See More
FMC Corporation Announces Q1 2026 Earnings Release Date
- Earnings Release Schedule: FMC Corporation has announced that it will release its Q1 2026 earnings on April 29, 2026, after market close, ensuring timely access to financial information for investors via PR Newswire and the company's website.
- Webcast Timing: The company will host a public webcast conference call on April 30, 2026, at 9:00 a.m. ET, aimed at enhancing transparency and facilitating direct communication with investors.
- Dial-In Information: The conference call offers multiple dial-in options, including local and toll-free numbers for the U.S., ensuring global investor participation and enhancing interaction between the company and its stakeholders.
- Company Overview: FMC is a global agricultural sciences company dedicated to helping growers adapt to environmental changes by providing innovative crop protection solutions, showcasing its commitment and strategic direction in sustainable agriculture.
See More
FMC Corp's Strategic Review Sparks Market Interest
- Significant Stock Volatility: FMC's stock has plummeted approximately 90% from its 2022 highs, facing heavy debt and patent expirations, yet the market shows disagreement on its future value, with a median analyst price target of $14.00 and a high of $43.00, indicating varied investor perspectives.
- New Product Development Progress: FMC is actively advancing 19 new active ingredients for weed controllers and insecticides, with four products currently in commercial rollout, projected to achieve approximately $200 million in sales by 2025, despite falling short of the $250 million target, reflecting strong market demand with a 54% year-over-year growth.
- Debt Management Commitment: FMC plans to pay down $1 billion in debt through asset sales and licensing agreements by 2026, including the previously announced sale of its Indian commercial business, while continuing its active ingredients manufacturing operations in India, aiming to improve financial health and bolster investor confidence.
- Enhanced Market Competitiveness: Rimisoxafen's
See More
FMC Shares Plummet, Investors Face Challenges
- Significant Stock Decline: FMC's shares have plummeted by approximately two-thirds over the past year, currently priced at $13.11 with a market cap of $1.6 billion, reflecting severe challenges and financial distress in the agricultural chemicals sector.
- Poor Financial Performance: FMC's revenue for 2024 is reported at $4.2 billion, with an expected 8% decline to $3.9 billion in 2025, alongside a 7% drop in adjusted EBITDA and a 15% decrease in adjusted EPS, indicating a decline in profitability under pressure from weak demand and patent expirations.
- Strategic Adjustments and Dividend Cut: The management's decision to cut dividends by 86% and consider
See More
FMC Shares Plummet, Yet Potential Investment Opportunities Arise
- Significant Stock Decline: FMC's shares have plummeted by approximately two-thirds over the past year due to both industry-specific and company-specific challenges, resulting in poor financial performance and diminished investor confidence.
- Strategic Decisions and Dividend Cut: The management has opted for an 86% dividend cut and is considering 'strategic alternatives,' including a potential sale of the company, which has led to negative investor reactions and further exacerbated the stock's decline.
- Future Revenue Guidance: According to management's 2026 guidance, revenue is expected to fall by 5.2% to $3.6 billion, with adjusted EBITDA projected between $670 million and $730 million, indicating ongoing financial pressures for the company.
- Potential Catalysts: Despite facing numerous challenges, FMC has two potential catalysts that could play out over the next year, including the launch of a new wave of patented crop protection products, although the market impact of these products may take years to materialize.
See More
